Internal Medicine · Manhasset, NY
NPI
1104880780
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
45 Orchard St
Manhasset, NY, 11030
Phone (516) 365-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
133,780 services
Medicare patients, 2024
807
Average age 77
Drug cost, 2024
$5.0M
2,172 prescriptions
Company payments, 2025
$33K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna K Imperato was code J3247 (injection, secukinumab, intravenous, 1 mg), 23,500 times for 23 patients. In total Anna K Imperato billed 133,780 services in 43 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3247 Injection, secukinumab, intravenous, 1 mg | Office | 23,500 | 23 | $13.76 | $323K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,800 | 23 | $9.14 | $181K |
| J0897 Injection, denosumab, 1 mg | Office | 9,840 | 104 | $20.61 | $203K |
| J9312 Injection, rituximab, 10 mg | Office | 5,140 | 19 | $61.40 | $316K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,122 | 36 | $0.10 | $432 |
| J0131 Injection, acetaminophen, not otherwise specified,10 mg | Office | 3,600 | 22 | $0.04 | $145 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,136 | 15 | $0.23 | $263 |
| 99213 Office E&M - Established | Office | 801 | 352 | $79.96 | $64K |
| 99214 Office E&M - Established | Office | 784 | 433 | $111.57 | $87K |
| 99232 Hospital E&M - Subsequent | Facility | 615 | 164 | $72.05 | $44K |
| 96415 Chemotherapy Administration | Office | 367 | 25 | $26.41 | $9,692 |
| 96372 Injection Administration | Office | 333 | 135 | $13.05 | $4,346 |
| 96413 Chemotherapy Administration | Office | 281 | 59 | $123.66 | $35K |
| 36415 Venipuncture Blood Collection | Office | 250 | 196 | $8.65 | $2,163 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 238 | 45 | $0.52 | $123 |
By year: 2022 $1.4M for 96,859 services; 2023 $1.4M for 105,570 services; 2024 $1.9M for 133,780 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 250 | 196 | $8.65 | $2,163 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna K Imperato prescribed most often to Medicare patients was Allopurinol, with 231 prescriptions and refills. In total Anna K Imperato wrote 2,172 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 231 | 631 | 61 | $3,329 |
| Sulfasalazine Dr Sulfasalazine | 219 | 446 | 74 | $13K |
| Hydroxychloroquine Sulfate Generic | 187 | 449 | 54 | $6,882 |
| Prednisone Generic | 166 | 233 | 59 | $1,653 |
| Methotrexate Methotrexate Sodium | 142 | 314 | 47 | $2,787 |
| Otezla Apremilast | 106 | 146 | 16 | $698K |
| Colchicine Generic | 103 | 238 | 44 | $9,164 |
| Tymlos Abaloparatide | 52 | 78 | 13 | $210K |
| Duloxetine Hcl Generic | 44 | 128 | 19 | $1,562 |
| Folic Acid Generic | 43 | 130 | 14 | $609 |
| Gabapentin Generic | 42 | 95 | 17 | $574 |
| Methylprednisolone Generic | 40 | 44 | 26 | $531 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 39 | 46 | Under 11 | $364K |
| Tramadol Hcl Generic | 39 | 39 | 11 | $303 |
| Tremfya Guselkumab | 28 | 57 | Under 11 | $432K |
Brand drugs: - claims; generic drugs: 1,431 claims; opioid claims: 102.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna K Imperato $33K ($33K in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 53 | $17K |
| Mallinckrodt Hospital Products Inc. | 23 | $12K |
| Amgen Inc. AMGN | 45 | $1,045 |
| Abbvie Inc. ABBV | 41 | $836 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $308 |
| UCB, Inc. UCB.BR | 14 | $299 |
| Pfizer Inc. PFE | 13 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $178 |
| GlaxoSmithKline, LLC. GSK | 7 | $166 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.